At Amgen, we are committed to advancing science and developing treatments for patients with serious illnesses, including many rare diseases. There are more than 10,000 different rare diseases impacting 400 million people globally. Rare diseases are complex and often underserved. They demand urgent attention and are a core and growing part of Amgen’s mission to serve patients.

Inspired by purpose that extends beyond our medicines, we stand firmly in support of the broader rare disease community across the globe. Amgen’s global #RAREis program provides education, awareness and resources – including scholarships and grants – for the entire rare disease community. Together, we aim to amplify awareness and unite communities to foster understanding and support for individuals touched by rare diseases worldwide. Through our unique approach, we actively participate, listen and learn from people living with rare diseases and their families. We believe that creating a more engaged patient community helps more people living with rare disease get the best possible care.